Table 2.
Predictors of adherence to HIV treatment and subsequent changes in health
|
|
Adhering to HAART treatment | Change in general health | ||||
|---|---|---|---|---|---|---|
| β | SE | P | β | SE | P | |
| Using HAART | — | 0.126 | 0.064 | 0.048 | ||
| Using HAART and adhering | — | −0.191 | 0.064 | 0.003 | ||
| Education (excluded, 0–11 years) | ||||||
| 12 years | 0.041 | 0.102 | 0.690 | 0.028 | 0.072 | 0.691 |
| 13–15 years | 0.183 | 0.102 | 0.073 | −0.035 | 0.073 | 0.633 |
| 16+ years | 0.308 | 0.122 | 0.012 | −0.088 | 0.086 | 0.305 |
| Black | −0.332 | 0.087 | 0.000 | −0.018 | 0.061 | 0.770 |
| Female | −0.182 | 0.102 | 0.074 | 0.196 | 0.071 | 0.006 |
Models also control for age, exposure route, census region of residence, CD4 count at baseline, self-reported general health at baseline, and insurance status; full results are shown in Appendix 1. The first three columns show probit regression estimates for adhering to HAART (among HAART users only). The second three columns show coefficient estimates from an ordered probit for whether general health improved, stayed the same, or got worse between baseline and second follow-up. Positive estimates in the ordered probit for change in health status indicate greater likelihood of condition worsening.